Replies to post #212541 on Biotech Values

[DewDiligence]

JNJ submits NDA for FDC consisting of Prezista and GILD’s TAF/Emtriva/Cobicistat (a/k/a D/C/F/TAF):

http://www.prnewswire.com/news-releases/janssen-submits-new-drug-application-to-us-food-and-drug-administration-for-the-first-darunavir-based-single-tablet-regimen-for-the-treatment-of-hiv-1-300524908.html

Please see #msg-133189036 and #msg-125100701 for related info.

[DewDiligence]

JNJ/GILD—EU brand name for D/C/F/TAF—>Symtuza:

https://www.businesswire.com/news/home/20170926005772/en

D/C/F/TAF is under FDA review (#msg-134878738).